Appoptosin-Mediated Caspase Cleavage of Tau Contributes to Progressive Supranuclear Palsy Pathogenesis
Authors:
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Appoptosin is a Novel Pro-Apoptotic Protein and Mediates Cell Death in NeurodegenerationJournal of Neuroscience, 2012
- Comparison of gait in progressive supranuclear palsy, Parkinson’s disease and healthy older adultsBMC Neurology, 2012
- CutA Divalent Cation Tolerance Homolog (Escherichia coli) (CUTA) Regulates β-Cleavage of β-Amyloid Precursor Protein (APP) through Interacting with β-Site APP Cleaving Protein 1 (BACE1)Journal of Biological Chemistry, 2012
- Identification of common variants influencing risk of the tauopathy progressive supranuclear palsyNature Genetics, 2011
- Induction of Intracellular Tau Aggregation Is Promoted by α-Synuclein Seeds and Provides Novel Insights into the Hyperphosphorylation of TauJournal of Neuroscience, 2011
- Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of NeurodegenerationNeuron, 2010
- Tau Reduction Prevents Aβ-Induced Defects in Axonal TransportScience, 2010
- Novel L284R MAPT Mutation in a Family with an Autosomal Dominant Progressive Supranuclear Palsy SyndromeNeurodegenerative Diseases, 2010
- Caspase activation precedes and leads to tanglesNature, 2010
- Caspase-cleaved Tau Expression Induces Mitochondrial Dysfunction in Immortalized Cortical NeuronsJournal of Biological Chemistry, 2009